Medochemie is a reputable brand that has been in operation since 1976. Founded by Dr. Andreas Pittas in Cyprus, the brand has expanded its reach across various promising markets worldwide.

With a strong presence in Europe, the Middle East & Africa, the Far East, and the Americas, Medochemie has established itself as a global player in the pharmaceutical industry. Medochemie operates through its 21 core offices and a network of trusted agents and partners in 107 countries. The brand boasts thirteen state-of-the-art manufacturing plants and facilities, located in Cyprus, the Netherlands, and Vietnam.

These facilities enable the production of a wide range of pharmaceutical products, comprising over 630 different medications classified in over 10 therapeutic categories. Quality is at the forefront of Medochemie's operations. The brand possesses an impressive 4,355 marketing authorization licenses and operates in full compliance with European guidelines, adhering to the strictest quality standards.

Medochemie's success can be attributed to its multinational and talented workforce of 1880 employees, who are dedicated to delivering excellence across their manufacturing plants and offices worldwide. As a founding member of Medicines for Europe (formerly EGA), Medochemie continues to prioritize innovation, trust, and the well-being of its customers. Whether it's partnering with other organizations, offering contract manufacturing services, or licensing and supplying pharmaceutical products, Medochemie remains committed to improving global healthcare through its high-quality and diverse portfolio of medications